UBS Raises Viatris (VTRS) Price Target as Cost Savings and Growth Outlook Improve

Viatris Inc. (NASDAQ:VTRS) is included among the 13 Best March Dividend Stocks to Buy. On February 27, UBS raised its price recommendation on Viatris Inc. (NASDAQ:VTRS) to $20 from $18. It maintained ...

Viatris Inc.: Viatris Maintains Dividend Policy for 2026 and Announces Quarterly Dividend

Viatris Inc. (Nasdaq: VTRS) today announced that on February 23, 2026, its Board of Directors approved a 2026 dividend policy ...

Viatris (VTRS) delivers solid 2025 growth and robust cash flow at deep value

Viatris Inc. (NASDAQ:VTRS) is one of the dirt cheap stocks to buy now. On February 26, Viatris reported a steady financial performance for the full-year 2025, generating $14.3 billion in total revenue ...
Insider Monkey

UBS Cite Efficient Capital Allocation and Rising Profits in Viatris Inc. (VTRS) Upgrade

Viatris Inc. (NASDAQ:VTRS) is among the 7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds. The third stock on our list of cheap pharmaceutical stocks is Viatris Inc. (NASDAQ:VTRS). TheFly ...

Viatris: Deep-Value Pharma With Emerging Growth Catalysts And Strong Cash Generation

Viatris anticipates $500 million in net cost savings by 2028, with reinvestment supporting higher-value brands. Click to read my latest analysis of VTRS stock.

Viatris Maintains Dividend Policy for 2026 and Announces Quarterly Dividend

Viatris Inc. (Nasdaq: VTRS) today announced that on February 23, 2026, its Board of Directors approved a 2026 dividend policy of 48 cents ($0.48) per share and declared a quarterly dividend of 12 ...